Price T Rowe Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 1,275,303 shares of REGN stock, worth $896 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,275,303

Previous 932,874 36.71%

Holding current value

$896 Million

Previous $980 Million 36.73%

% of portfolio

0.15%

Previous 0.12%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1024.09 - $1201.76 $351 Million - $412 Million	342,429 Added 36.71%	1,275,303 $1.34 Billion
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $26.7 Million - $32.4 Million	30,261 Added 3.35%	932,874 $980 Million
Q1 2024 May 15, 2024	BUY	$902.69 - $993.35 $167 Million - $183 Million	184,561 Added 25.7%	902,613 $869 Million
Q4 2023 Feb 14, 2024	SELL	$775.18 - $881.7 $1.16 Billion - $1.32 Billion	-1,499,613 Reduced 67.62%	718,052 $631 Million
Q3 2023 Nov 14, 2023	SELL	$692.45 - $844.37 $24 Million - $29.2 Million	-34,598 Reduced 1.54%	2,217,665 $1.83 Billion
Q2 2023 Aug 14, 2023	BUY	$700.03 - $830.35 $51.8 Million - $61.5 Million	74,031 Added 3.4%	2,252,263 $1.62 Billion
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $309 Million - $376 Million	454,510 Added 26.37%	2,178,232 $1.79 Billion
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $18.9 Million - $20.6 Million	-26,839 Reduced 1.53%	1,723,722 $1.24 Billion
Q3 2022 Nov 14, 2022	BUY	$573.97 - $724.32 $32.3 Million - $40.7 Million	56,253 Added 3.32%	1,750,561 $1.21 Billion
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $446 Million - $601 Million	813,967 Added 92.46%	1,694,308 $1 Billion
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $19.6 Million - $23 Million	-32,914 Reduced 3.6%	880,341 $615 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $56.2 Million - $69.4 Million	103,415 Added 12.77%	913,255 $577 Million
Q3 2021 Nov 15, 2021	SELL	$574.03 - $680.96 $8.61 Million - $10.2 Million	-15,004 Reduced 1.82%	809,840 $490 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $17.9 Million - $21.2 Million	-37,899 Reduced 4.39%	824,844 $461 Million
Q1 2021 May 17, 2021	SELL	$446.73 - $548.2 $2.35 Million - $2.88 Million	-5,256 Reduced 0.61%	862,743 $408 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $415 Million - $528 Million	867,999 New	867,999 $419 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History